Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. J of Skin. 2024;8(6):s506. doi:10.25251/skin.8.supp.506